{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:31:46Z","timestamp":1792801906725,"version":"4.5.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003329","name":"Ministerio de Econom\u00eda y Competitividad","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalmicrobiologyandinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.cmi.2019.10.034","type":"journal-article","created":{"date-parts":[[2019,11,19]],"date-time":"2019-11-19T11:48:52Z","timestamp":1574164132000},"page":"753-759","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":51,"title":["Emerging non-13-valent pneumococcal conjugate vaccine (PCV13) serotypes causing adult invasive pneumococcal disease in the late-PCV13 period in Spain"],"prefix":"10.1016","volume":"26","author":[{"given":"A.","family":"Gonz\u00e1lez-D\u00edaz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"C\u00e0mara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Ercibengoa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Cercenado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Larrosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.D.","family":"Quesada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Fontanals","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Cubero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.M.","family":"Marim\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Yuste","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Ardanuy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cmi.2019.10.034_bib1","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1086\/594125","article-title":"Epidemiology of invasive pneumococcal disease among adult patients in Barcelona before and after pediatric 7-valent pneumococcal conjugate vaccine introduction, 1997\u20132007","volume":"48","author":"Ardanuy","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2019.10.034_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0175224","article-title":"Decrease of invasive pneumococcal disease (IPD) in adults after introduction of pneumococcal 13-valent conjugate vaccine in Spain","volume":"12","author":"C\u00e0mara","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.cmi.2019.10.034_bib3","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1111\/j.1469-0691.2010.03182.x","article-title":"Changes in antimicrobial resistance, serotypes and genotypes in Streptococcus pneumoniae over a 30-year period","volume":"16","author":"Li\u00f1ares","year":"2010","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2019.10.034_bib4","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1086\/524660","article-title":"Emergence of invasive pneumococcal disease caused by nonvaccine serotypes in the era of 7-valent conjugate vaccine","volume":"46","author":"Munoz-Almagro","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2019.10.034_bib5","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/S0140-6736(09)61204-6","article-title":"Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates","volume":"374","author":"O\u2019Brien","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.cmi.2019.10.034_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pbio.1002394","article-title":"Horizontal DNA transfer mechanisms of bacteria as weapons of intragenomic conflict","volume":"14","author":"Croucher","year":"2016","journal-title":"PLoS Biol"},{"key":"10.1016\/j.cmi.2019.10.034_bib7","doi-asserted-by":"crossref","first-page":"R107","DOI":"10.1186\/gb-2010-11-10-r107","article-title":"Structure and dynamics of the pan-genome of Streptococcus pneumoniae and closely related species","volume":"11","author":"Donati","year":"2010","journal-title":"Genome Biol"},{"key":"10.1016\/j.cmi.2019.10.034_bib8","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1126\/science.1171908","article-title":"Hyper-recombination, diversity, and antibiotic resistance in pneumococcus","volume":"324","author":"Hanage","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.cmi.2019.10.034_bib9","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.eimc.2018.07.012","article-title":"Pneumococcal disease and conjugate vaccines","volume":"36","author":"C\u00e0mara","year":"2018","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"10.1016\/j.cmi.2019.10.034_bib10","doi-asserted-by":"crossref","first-page":"6178","DOI":"10.1016\/j.vaccine.2015.10.015","article-title":"Invasive disease potential of pneumococci before and after the 13-valent pneumococcal conjugate vaccine implementation in children","volume":"33","author":"Varon","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.cmi.2019.10.034_bib11","doi-asserted-by":"crossref","first-page":"2953","DOI":"10.1080\/21645515.2016.1210744","article-title":"Pneumococcal vaccination coverages among low-, intermediate-, and high-risk adults in Catalonia","volume":"12","author":"Vila-Corcoles","year":"2016","journal-title":"Hum Vaccines Immunother"},{"key":"10.1016\/j.cmi.2019.10.034_bib12","doi-asserted-by":"crossref","first-page":"6802","DOI":"10.1016\/j.vaccine.2012.09.019","article-title":"Impact and effectiveness of 23-valent pneumococcal polysaccharide vaccine against invasive pneumococcal disease in the elderly in England and Wales","volume":"30","author":"Andrews","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.cmi.2019.10.034_bib13","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S1473-3099(18)30052-5","article-title":"Rapid increase in non-vaccine serotypes causing invasive pneumococcal disease in England and Wales, 2000\u201317: a prospective national observational cohort study","volume":"18","author":"Ladhani","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.cmi.2019.10.034_bib14","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/S1473-3099(18)30349-9","article-title":"Incidence of paediatric pneumococcal meningitis and emergence of new serotypes: a time-series analysis of a 16-year French national survey","volume":"18","author":"Ouldali","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.cmi.2019.10.034_bib15","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.3201\/eid2011.131215","article-title":"Spread of Streptococcus pneumoniae serotype 8-ST63 multidrug-resistant recombinant clone, Spain","volume":"20","author":"Ardanuy","year":"2014","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.cmi.2019.10.034_bib16","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1128\/CMR.00058-15","article-title":"Biological and Epidemiological features of antibiotic-resistant Streptococcus pneumoniae in pre- and post-conjugate vaccine eras: a United States perspective","volume":"29","author":"Kim","year":"2016","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.cmi.2019.10.034_bib17","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/S2213-2600(17)30110-8","article-title":"Effect of high-valency pneumococcal conjugate vaccines on invasive pneumococcal disease in children in SpIDnet countries: an observational multicentre study","volume":"5","author":"Savulescu","year":"2017","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.cmi.2019.10.034_bib18","doi-asserted-by":"crossref","first-page":"4565","DOI":"10.1016\/j.vaccine.2016.07.031","article-title":"Unaltered pneumococcal carriage prevalence due to expansion of non-vaccine types of low invasive potential 8 years after vaccine introduction in Stockholm, Sweden","volume":"34","author":"Lindstrand","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.cmi.2019.10.034_bib19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0220453","article-title":"Limited indirect effects of an infant pneumococcal vaccination program in an aging population","volume":"14","author":"van der Linden","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.cmi.2019.10.034_bib20","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1136\/thoraxjnl-2018-211767","article-title":"Effect of childhood pneumococcal conjugate vaccination on invasive disease in older adults of 10 European countries: implications for adult vaccination","volume":"74","author":"Hanquet","year":"2019","journal-title":"Thorax"},{"key":"10.1016\/j.cmi.2019.10.034_bib22","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1128\/jcm.33.9.2233-2239.1995","article-title":"Interpreting chromosomal DNA restriction patterns produced by pulsed- field gel electrophoresis: criteria for bacterial strain typing","volume":"33","author":"Tenover","year":"1995","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.cmi.2019.10.034_bib23","doi-asserted-by":"crossref","first-page":"3049","DOI":"10.1099\/00221287-144-11-3049","article-title":"A\u00a0multilocus sequence typing scheme for Streptococcus pneumoniae: identification of clones associated with serious invasive disease","volume":"144","author":"Enright","year":"1998","journal-title":"Microbiology"},{"key":"10.1016\/j.cmi.2019.10.034_bib24","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1128\/JCM.02243-09","article-title":"Revisiting pneumococcal carriage by use of broth enrichment and PCR techniques for enhanced detection of carriage and serotypes","volume":"48","author":"Carvalho","year":"2010","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.cmi.2019.10.034_bib25","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1080\/21645515.2018.1532249","article-title":"Safety and immunogenicity of 15-valent pneumococcal conjugate vaccine (PCV-15) compared to PCV-13 in healthy older adults","volume":"15","author":"Stacey","year":"2019","journal-title":"Hum Vaccines Immunother"},{"key":"10.1016\/j.cmi.2019.10.034_bib26","doi-asserted-by":"crossref","first-page":"6201","DOI":"10.1016\/j.vaccine.2019.08.048","article-title":"Phase 1 trial of a 20-valent pneumococcal conjugate vaccine in healthy adults","volume":"37","author":"Thompson","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.cmi.2019.10.034_bib27","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1371\/journal.pone.0153602","article-title":"Population structure of Streptococcus pneumoniae causing invasive disease in adults in Portugal before PCV13 availability for adults: 2008\u20132011","volume":"11","author":"Hor\u00e1cio","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.cmi.2019.10.034_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0210278","article-title":"Regional variations in serotype distribution and vaccination status in children under six years of age with invasive pneumococcal disease in Germany","volume":"14","author":"Perniciaro","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.cmi.2019.10.034_bib29","doi-asserted-by":"crossref","first-page":"6310","DOI":"10.1016\/j.vaccine.2019.08.059","article-title":"Pneumococcal conjugate vaccine against serotype 3 pneumococcal pneumonia in adults: a systematic review and pooled analysis","volume":"37","author":"McLaughlin","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.cmi.2019.10.034_bib30","article-title":"Changes in invasive pneumococcal disease spectrum after 13 valent pneumococcal conjugate vaccine implementation","author":"Levy","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2019.10.034_bib31","doi-asserted-by":"crossref","first-page":"e213","DOI":"10.1016\/S1473-3099(18)30660-1","article-title":"Making sense of differences in pneumococcal serotype replacement","volume":"19","author":"Lewnard","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.cmi.2019.10.034_bib32","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/nrmicro2011","article-title":"The rise and fall of bacterial clones: Streptococcus pneumoniae","volume":"6","author":"Henriques-Normark","year":"2008","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.cmi.2019.10.034_bib33","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.2147\/IDR.S165093","article-title":"Overview of pneumococcal serotypes and genotypes causing diseases in patients with chronic obstructive pulmonary disease in a Spanish hospital between 2013 and 2016","volume":"11","author":"Shoji","year":"2018","journal-title":"Infect Drug Resist"},{"key":"10.1016\/j.cmi.2019.10.034_bib34","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1128\/JCM.01763-10","article-title":"Analysis of invasiveness of pneumococcal serotypes and clones circulating in Portugal before widespread use of conjugate vaccines reveals heterogeneous behavior of clones expressing the same serotype","volume":"49","author":"S\u00e1-Leao","year":"2011","journal-title":"J\u00a0Clin Microbiol"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X19305890?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X19305890?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T07:25:13Z","timestamp":1761117913000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X19305890"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":33,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["S1198743X19305890"],"URL":"https:\/\/doi.org\/10.1016\/j.cmi.2019.10.034","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Emerging non-13-valent pneumococcal conjugate vaccine (PCV13) serotypes causing adult invasive pneumococcal disease in the late-PCV13 period in Spain","name":"articletitle","label":"Article Title"},{"value":"Clinical Microbiology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cmi.2019.10.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}